Daiwa Securities Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
304
| – | – | ﹤0.01% | 1122 |
|
|
2025
Q1 | $10K | Hold |
304
| – | – | ﹤0.01% | 1094 |
|
|
2024
Q4 | $16K | Hold |
304
| – | – | ﹤0.01% | 1092 |
|
|
2024
Q3 | $16K | Buy |
304
+31
| +11% | +$1.63K | ﹤0.01% | 1109 |
|
|
2024
Q2 | $12K | Hold |
273
| – | – | ﹤0.01% | 1147 |
|
|
2024
Q1 | $13K | Hold |
273
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q4 | $10K | Buy |
273
+74
| +37% | +$2.71K | ﹤0.01% | 1161 |
|
|
2023
Q3 | $6K | Hold |
199
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q2 | $4K | Hold |
199
| – | – | ﹤0.01% | 1185 |
|
|
2023
Q1 | $3K | Hold |
199
| – | – | ﹤0.01% | 1173 |
|
|
2022
Q4 | $4K | Hold |
199
| – | – | ﹤0.01% | 1158 |
|
|
2022
Q3 | $4K | Hold |
199
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q2 | $4K | Buy |
199
+67
| +51% | +$1.35K | ﹤0.01% | 1171 |
|
|
2022
Q1 | $3K | Hold |
132
| – | – | ﹤0.01% | 1208 |
|
|
2021
Q4 | $4K | Hold |
132
| – | – | ﹤0.01% | 1209 |
|
|
2021
Q3 | $3K | Buy |
132
+70
| +113% | +$1.59K | ﹤0.01% | 1204 |
|
|
2021
Q2 | $1K | Hold |
62
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q1 | $1K | Hold |
62
| – | – | ﹤0.01% | 1189 |
|
|
2020
Q4 | $1K | Buy |
+62
| New | +$1K | ﹤0.01% | 1166 |
|
|
2019
Q4 | – | Sell |
-153
| Closed | -$2K | – | 1196 |
|
|
2019
Q3 | $2K | Hold |
153
| – | – | ﹤0.01% | 1112 |
|
|
2019
Q2 | $4K | Hold |
153
| – | – | ﹤0.01% | 1097 |
|
|
2019
Q1 | $3K | Sell |
153
-67
| -30% | -$1.31K | ﹤0.01% | 1092 |
|
|
2018
Q4 | $7K | Buy |
+220
| New | +$7K | ﹤0.01% | 1012 |
|